The global scaffold technology market size is anticipated to
reach USD 1.5 billion by 2024, according to a new report by Grand View
Research, Inc.Evolution of scaffold technology, which facilitates the
transplantation process, has created opportunities to address tissue
engineering-associated challenges such as vascularization. Also, scaffolds are
used in the treatment of damaged and diseased organs or tissues to provide
support to implants that are surgically inserted into the patient’s body. This
is expected to further support the emergence of this vertical.
Rise in the aging population and the
number of organ defunctionalization cases coupled with the demand for effective
treatments are some of the factors promoting the adoption of scaffold
technology.
Browse full research report on Scaffold Technology Market: https://www.grandviewresearch.com/industry-analysis/scaffold-technology-market
Further Key Findings from the Study Suggest:
- In 2015, hydrogels-based scaffolds dominated the market with
a share of over 41% with respect to revenue generation owing to their
higher availability as well as continual progress in their development.
Moreover, their promising use as cartilage tissue engineering scaffolds,
which enable simultaneous cell growth and drug delivery, is fueling their
adoption.
- Even though nanofiber-based scaffolds are estimated to
exhibit the lowest market penetration in the current scenario, this
segment is expected to witness the fastest growth rate in the coming years
due to their ability to mimic the nanoscale properties and structural
characteristics of native extracellular matrix; this factor is expected to
increase their incorporation in regenerative medicine and other clinical
applications.
- Biotechnology and pharmaceutical organizations held the
largest share in 2015 and are expected to witness considerable growth over
the forecast period due to the demand for robust tools in metabolic and
toxicology profiling of drug moieties during the process of drug
development. Also, several biotechnological companies have begun investing
in the development of novel products targeting this vertical, which is
expected to boost revenue generation through these entities.
- In 2014, North America emerged as one of the largest markets.
This is attributable to the developed healthcare infrastructure and
presence of large number of key participants operating in this region.
Asia pacific is expected to be one of the fastest growing regional
segments owing to the rapidly improving infrastructure and favorable
government initiatives pertaining to research and development in the
pharmaceutical industry.
- Some of the key players operating the scaffold
technology market include Merck KGaA (Sigma-Aldrich Co. LLC);Thermo Fisher
Scientific, Inc.; 3D Biotek LLC; Molecular Matrix, Inc; ReproCELL Europe
Ltd (Reinnervate); Xanofi; Pelo Biotech GmbH; Corning, Inc; Becton,
Dickinson and Company; 3D Biomatrix; Avacta Life Sciences Limited;
Nanofiber Solutions; NuVasive, Inc; Vericel Corporation; Molecular
Partners; Acelity (LifeCell Corporation); and Medtronic (Covidien plc).
- These players are undertaking different market strategies to
maintain their dominance in the market. These strategic endeavors include
new product development, acquisitions and mergers, partnerships, and
global expansion efforts.
- Scaffold technology is considered as the leading candidate
employed to perform 3D-culture assays including high throughput screening,
cell to matrix interactions, cell to cell interactions, cell migration
assays, and transfections, which collectively accounted for the largest
segment share in 2015 and is anticipated to witness lucrative growth in
the coming years. The significant share is attributed to the increasing
use of scaffold technology to study cellular behavior and understand the
underlying mechanism of diseases.
Browse
request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/scaffold-technology-market/request/rs1
Grand View Research has segmented the scaffold technology market
on the basis of types, application, end use, and region:
Global Outlook, by Type (Revenue, USD Million, 2013 - 2024)
- Hydrogels
- Polymeric
Scaffolds
- Micro-patterned
Surface Microplates
- Nanofiber-based
Scaffolds
Global Outlook, by Application (Revenue, USD Million, 2013 - 2024)
- Cancer
- Tissue
Engineering & Clinical Application
- Drug
development
- Stem
cell research
- Others
Global Outlook, by End Use (Revenue, USD Million, 2013 - 2024)
- Biotechnology
and Pharmaceutical Organizations
- Research
Laboratories and Institutes
- Hospitals
and Diagnostic Centers
- Others
Regional Outlook (Revenue, USD Million, 2013 - 2024)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- China
- Japan
- Latin
America
- Brazil
- MEA
- South
Africa
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
For
more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment